Trastuzumab induced anti-tumor effects through two ways: intracellular anti-tumor effects by inhibiting downstream effectors of HER-2 signaling, and extracellular anti-tumor effects by recruiting immunity (Oh and Bang 2020; Augustin et al. 2022). The gene discussed is ERBB2; the disease is neoplasm.